Ingevity Corporation

Ingevity Corporation

NGVTNYSE / NASDAQBasic MaterialsMid cap

$53.75-$2.21 (-3.9%)

Last close · Data as of Nov 20, 2026

Market cap
$2.3B
P/E
-13.8x
EV / EBITDA
83.6x
Revenue
$1.2B
Net margin
-14.3%
ROCE
20.0%

+13.2% over the last year

Ingevity Corporation price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-23.9%
3M
-22.4%
6M
-18.7%
1Y
+13.2%
5Y
-31.8%

52-week range

Day change -$2.21 (-3.9%) from $56 to $54 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in NGVT, bought on each weekday since 2021.

News & filings

What Ingevity filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 167 million US dollars in fiscal 2025.

Strengths (1)

  • Operating margin of 22.4% against a peer median of 7.5%.
  • Shareholders' equity is small against the company's size, so return on equity and debt to equity are not shown.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Read moreShow less

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Sector
Basic Materials
Shares outstanding
35.5M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$2.3B
P/E
-13.8x
P/B
77.4x
EV / EBITDA
83.6x
EV / Sales
3.0x
P/S
2.0x
52-week high
$77.87
52-week low
$47.48

Profitability

Operating margin
22.4%
Net margin
-14.3%
EBITDA margin
3.5%
ROE
-562.6%
ROCE
20.0%
ROA
-10.1%
Asset turnover
0.71

Growth

Revenue
$1.2B
Revenue growth, 1Y
-2.7%
Revenue CAGR, 3Y
-11.2%
Net profit growth, 1Y
-61.2%
Free cash flow
$273.5M

Solvency

Current ratio
1.33
Debt / Equity
41.84
Debt / Assets
0.75
CFO / Net profit
-1.98
Cash / Market cap
3.4%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$1.2B
Cost of revenue$706.1M
Gross profit$461.5M
Operating expenses$199.6M
Research and development$28.4M
Selling, general and administrative$171.2M
Operating income$261.9M
Interest and other-$404.0M
Pretax income-$142.1M
Tax and other$25.0M
Net income-$167.1M

Revenue and net profit

Revenue fell 2.7% in FY2025; net profit is the dashed line.

Ingevity Corporation revenue and net profit by fiscal year
Ingevity Corporation revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.7B$211.6M
FY2023$1.2B-$5.4M
FY2024$1.2B-$430.3M
FY2025$1.2B-$167.1M

Cash flows

FY2025: $331.2M from operations, $273.5M free after investment (dashed).

Ingevity Corporation operating and free cash flow by fiscal year
Ingevity Corporation operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$313.4M$170.9M
FY2023$205.1M$95.3M
FY2024$128.6M$51.0M
FY2025$331.2M$273.5M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.2B-2.7%1Y
EBITDA
$41.4M-35.7%1Y
Net profit
-$167.1M
Cash from operations
$331.2M+157.5%1Y
Free cash flow
$273.5M+436.3%1Y
Revenue CAGR, 3Y
-11.2%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.2B$41.4M-$167.1M$273.5M-562.6%-2.7%-61.2%

Monthly returns

Month-by-month returns of NGVT across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$1.7B
Liabilities$1.6B
Equity$29.7M
Paid-in capital$195.7M
Retained earnings$404.9M
Treasury stock$571.8M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Basic Materials companies placed by value, growth and quality; NGVT highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

  1. Ingevity Corporation (this company)3.0x

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Ingevity CorporationNGVTthis company$2.3B-13.8x77.4x-562.6%83.6x
The Chemours CompanyCC$3.3B—13.0x-154.4%21.0x
Hawkins, Inc.HWKN$3.2B39.0x6.0x15.3%19.6x
Kaiser Aluminum CorporationKALU$3.1B27.1x3.7x13.6%12.8x
Alpha Metallurgical Resources, Inc.AMR$2.7B-44.4x1.8x-4.0%25.0x
WD-40 CompanyWDFC$2.7B30.1x10.2x33.8%24.5x
Quaker Chemical CorporationKWR$2.4B-982.0x1.8x-0.2%21.9x
Boise Cascade CompanyBCC$2.4B18.1x1.2x6.4%6.7x
Minerals Technologies Inc.MTX$2.4B-129.3x1.4x-1.1%22.9x
Peer median—18.1x2.7x3.1%21.5x

Year-to-date ROI

NGVT since 1 January, against earlier years.

Historical volatility

NGVT's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Ingevity Corporation operating margin by fiscal year
Ingevity Corporation operating margin by fiscal year
DateOperating margin
FY202220.4%
FY202321.2%
FY202423.5%
FY202522.4%
LineFY2025
Cost of revenueCost Of Revenue$706.1M
Gross profitGross Profit$461.5M
Operating expensesOperating Expense$199.6M
Research and developmentResearch And Development$28.4M
Selling, general and administrativeSelling General And Administration$171.2M
Total expensesTotal Expenses$905.7M
Operating incomeOperating Income$261.9M
Pretax incomePretax Income-$142.1M

Learn while you research

Academy chapters picked for Ingevity Corporation and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Leverage RatiosDebt/Equity of 41.84 is elevated, understand what that means for solvency.6 min read
  3. 03 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →